Clinical Trials Directory

Trials / Completed

CompletedNCT00068978

Analysis of Immune Responses to HIV Vaccines

Flow Cytometry Study of T Cell Responses to HIV Vaccines

Status
Completed
Phase
Study type
Observational
Enrollment
200 (planned)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Sex
All
Age
Healthy volunteers
Accepted

Summary

This study will evaluate a test designed to measure immune system responses to HIV and HIV vaccines.

Detailed description

Assays for HIV-specific human CD4 and CD8 T cell immunity are needed in order to evaluate the immune response to HIV vaccines. Such assays should be robust, reproducible, and amenable to high throughput analysis of clinical specimens. Cytokine flow cytometry (CFC) assays can reliably and specifically detect human CD4 and CD8 T cell responses to AIDS-related opportunistic infections, including those caused by cytomegalovirus, Mycobacterium tuberculosis, the Mycobacterium avium complex, cryptococcus, and human papillomavirus. The purpose of this study is to devise and evaluate a similar CFC assay for the detection and quantitation of CD4 and CD8 T cell responses against HIV. This study will evaluate a "Gag-IFNg CFC" assay by comparing the results of this assay with results from other assays of immune phenotype and function in long-term nonprogressors, untreated patients with progressive HIV disease, and recipients of candidate HIV vaccines. The study will also examine HIV-specific immune responses in HIV infected individuals who appear to exhibit significant immune protection from HIV disease. Participants in this study will be drawn from other studies currently underway. As a part of those studies, participants will have regular blood tests. Blood samples from those studies will be used in this study. No participants will be directly enrolled in this study.

Conditions

Timeline

Start date
2003-04-01
First posted
2003-09-16
Last updated
2007-09-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00068978. Inclusion in this directory is not an endorsement.